Years > 2014 > September, 2014 > Friday, September 26, 2014
Next Article Next
Next Previous Article
79 FR 187 pgs. 57940-57941 - Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications

Type: NOTICEVolume: 79Number: 187Pages: 57940 - 57941
Docket number: [Docket Nos. FDA-2014-M-0327, FDA-2014-M-0434, FDA-2014-M-0552, FDA-2014-M-0553, FDA-2014-M-0690; FDA-2014-M-0691, FDA-2014-M-0692, FDA-2014-M-0726, FDA-2014-M-0727, FDA-2014-M-0866, and FDA-2014-M-0872]
FR document: [FR Doc. 2014-22987 Filed 9-25-14; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: Food and Drug Administration
Official PDF Version:  PDF Version
Pages: 57940, 57941

[top] page 57940

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket Nos. FDA-2014-M-0327, FDA-2014-M-0434, FDA-2014-M-0552, FDA-2014-M-0553, FDA-2014-M-0690; FDA-2014-M-0691, FDA-2014-M-0692, FDA-2014-M-0726, FDA-2014-M-0727, FDA-2014-M-0866, and FDA-2014-M-0872]

Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Notice.

SUMMARY:

The Food and Drug Administration (FDA) is publishing a list of premarket approval applications (PMAs) that have been approved. This list is intended to inform the public of the availability of safety and effectiveness summaries of approved PMAs through the Internet and the Agency's Division of Dockets Management.

ADDRESSES:


[top] Submit written requests for copies of summaries of safety and page 57941 effectiveness data to the Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. Please cite the appropriate docket number as listed in table 1 when submitting a written request. See the SUPPLEMENTARY INFORMATION section for electronic access to the summaries of safety and effectiveness.

FOR FURTHER INFORMATION CONTACT:

Nicole Wolanski, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, Rm. 1650, Silver Spring, MD 20993-0002, 301-796-6570.

SUPPLEMENTARY INFORMATION:

I. Background

In accordance with sections 515(d)(4) and (e)(2) of the Federal Food, Drug, and Cosmetic Act (the FD&C Act) (21 U.S.C. 360e(d)(4) and (e)(2)), notification of an order approving, denying, or withdrawing approval of a PMA will continue to include a notice of opportunity to request review of the order under section 515(g) of the FD&C Act (21 U.S.C. 360e(g)). The 30-day period for requesting reconsideration of an FDA action under § 10.33(b) (21 CFR 10.33(b)) for notices announcing approval of a PMA begins on the day the notice is placed on the Internet. Section 10.33(b) provides that FDA may, for good cause, extend this 30-day period. Reconsideration of a denial or withdrawal of approval of a PMA may be sought only by the applicant; in these cases, the 30-day period will begin when the applicant is notified by FDA in writing of its decision.

The regulations provide that FDA publish a quarterly list of available safety and effectiveness summaries of PMA approvals and denials that were announced during that quarter. The following is a list of approved PMAs for which summaries of safety and effectiveness were placed on the Internet from April 1, 2014, through June 30, 2014. There were no denial actions during this period. The list provides the manufacturer's name, the product's generic name or the trade name, and the approval date.

PMA No., Docket No. Applicant Trade name Approval date
P130016, FDA-2014-M-0327 Cochlear Americas Nucleus® HybridTM L24 Cochlear Implant System March 20, 2014.
P120020, FDA-2014-M-0434 Abbott Vascular (IDEV Technologies, Inc.) SUPERA® Peripheral Stent System March 28, 2014.
P010015/S205, FDA-2014-M-0553 Medtronic, Inc Cardiac Resynchronization Therapy Pacemaker (CRT-P) Devices April 10, 2014.
P010031/S381, FDA-2014-M-0553 Medtronic, Inc Cardiac Resynchronization Therapy Defibrillator (CRT-D) Devices April 10, 2014.
P100020/S008, FDA-2014-M-0552 Roche Molecular Systems, Inc cobas® HPV Test April 24, 2014.
P130008, FDA-2014-M-0690 Inspire Medical Systems, Inc Inspire Upper Airway Stimulation (UAS) system April 30, 2014.
P110005, FDA-2014-M-0691 IBSA Institut Biochimique SA Gel-SynTM Sinovial (Sodium Hyaluronate 0.8%) May 9, 2014.
P110041, FDA-2014-M-0692 Siemens Healthcare Diagnostics ADVIA Centaur® HBsAgII, ADVIA Centaur® HBsAg Confirmatory and ADVIA Centaur® HBsAg Quality Control Material May 16, 2014.
P110027, FDA-2014-M-0726 QIAGEN Manchester Ltd therascreen® KRAS RGQ PCR Kit May 23, 2014.
P100045, FDA-2014-M-0727 CardioMEMS, Inc CardioMEMSTM HF System May 28, 2014.
P130027, FDA-2014-M-0866 QIAGEN, Inc artus® CMV RGQ MDx Kit June 2, 2014.
P040024/S072, FDA-2014-M-0872 Valeant Pharmaceuticals North America LLC/Medicis Restylane Silk Injectable Gel June 13, 2014.

II. Electronic Access

Persons with access to the Internet may obtain the documents at http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/PMAApprovals/default.htm.

Dated: September 23, 2014

Leslie Kux,

Assistant Commissioner for Policy.

[FR Doc. 2014-22987 Filed 9-25-14; 8:45 am]

BILLING CODE 4164-01-P